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Summary: A turbidimetric assay for the quantification of apolipoprotein A-II in serum is described. Its
adaptation for the Cobas Bio Analyser (Hoffmann La Röche) is reported.
Regression analysis of apolipoprotein A-II values measured by turbidimetry revealed a good measure of
agreement with the data obtained by radial immunodiffusion (RID) (i\= 0.90, y = 0.97x + 0.021, n =
100) äs well äs with data obtained by immunonephelometry (r = 0.838, y = 0.925x + 0.029, n = 34). A
Variation coefficient of 3.2% (n = 18) was found in relation to the precision in the series and a Variation
coefficient of 3.5% (n = 36) in relation to day to day precision.
Turbidimetrische Bestimmung von Apolipoprotein A-II
Zusammenfassung: Es wird ein turbidimetrisches Verfahren zur Bestimmung von Apolipoprotein A-II im
Serum beschrieben, das an den Analysator Cobas Bio (Hoffmann La Röche) adaptiert wurde.
Die Regressionsanalyse der mittels Turbidimetrie ermittelten Apolipoprotein A-II-Werte ergab eine gute
Übereinstimmung mit Apolipoprotein A-II-Werten, die mittels radialer Immundiffüsion (RID) (r = 0,90,
y = 0,97x + 0,021, = 100) bzw. mittels Immuntiephelometrie bestimmt wurden (r = 0,838, y = 0,925x +
0,029, n = 34). Der Variationskoeffizient in der Serie betrug 3,2% (n = 18) und der Variationskoeffizient
von Tag zu Tag 3,5% (n = 36).
Introduction
Epidemiological (1^-5) and clinical (6, 7) studies in
recent years have shown that HDL cholesterpl is
an indicator of coronary heart disease. The possible
relatipn of further HDL components (HDL
phospholipids, HDL apolipoprotein AJ, HDL apo-
lipoprotein A-Il) to the risk of cpronafy heart disease,
however, is until now unknown. This may be due
to the fact that the analysis of phospholipids and
apolipoproteins is more laborious thän the analysis
of cholesterpl.
Among the different methods used for the routine
analysis of apolipoprotein A-I immunonephelometry
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may be the method of choice (8 — 11). For the de-
termination of apolipoprotein A-II numerous
methods — fadioimmunoassay (12, 13), radial im-
munodiffusion (RID) (14), enzyme immuno assay
(15) and immunonephelometry (16, 17) — have been
described. However, most of these methods are la-
borious and not suitable for processing the large
number of samples required for epidemiological stud-
ies.
In the present study we report the development of a
turbidimetric end point assay for the determination of
apolipoprotein A-II using the Cobas Bio Centrifugal
Aiialyser (Hoffmann La Röche).
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Materials and Methods
Sample material
We uscd samples of the serum collccted for the "Prospective
epidemiological study in Company employees in Westfalia" re-
ported elsewhere (18).
Antibodies
As apolipoprotein A-II antibody, we used the commercial anti-
body from rabbits Anti A-II Immuno, order No. 4833005,
Immuno Co., D-6900 Heidelberg, FRG. In two dimensional
immunoelectrophoresis the antibody was monospecific for apo-
lipoprotein A-II, using isolated LDL (1.006-1.040 kg/l UZ
serum fraction) and isolated apolipoproteins (apolipoprotein
A-I, A-II, C-I, C-II, C-III, B) s antigens.
Turbidimetry
The turbidimetric assay of apolipoprotein A-II was performed
using the Cobas Bio Analyser (Hoffmann La R che). The
reagent contained:
— 300 μΐ antibody solution, diluted 1:15 with a phosphate
buffered polyethylenglycol solution (Beckman Im-
munochemical System)
— 20 μΐ diluted sample (dilution l: 150 with detergent, Immuno
Co., D-6900 Heidelberg, FRG, order no. 4998005)
- 10 μΐ Η2Ο
After an incubation period of 60 minutes at 25 °C changes in
turbidity were recorded. For calibration the Standard (im-
munoneph Reference Standard Apoproteins human Immuno
Co., D-6900 Heidelberg, FRG, order No. 4380105) was diluted
1:100, 1:150, 1:200, 1:250, 1:300 and 1:400 with the detergent.
The parameter list for the Cobas Bio was s follows:
1 units
2 calculation factor
3 Standard l conc
3 Standard 2 conc
3 Standard 3 conc
3 Standard 4 conc
3 Standard 5 conc
3 Standard 6 conc
6 limit
7 temperature (°C)
8 type of analysis
9 wavelength (nm)
10 sample volume (μΐ)
11 diluent volume (μΐ)
12 reagent volume (μΐ)
13 incubation time (s)
14 start reagent volume (μΐ)
15 time of first reading (s)
16 time interval (s)
17 number of readings
18 blankingmode
19 printout mode
8
1000
0.2479 (1:400)
0.3305 (1:300)
0.3966(1:250)
0.4958 (1:200)
0.6610 (1:150)
0.9901 (1:100)
0
25.0
7.5
340
20
10
300
0
0
10.0
300
12 £: 60 min
l
l
Immunonephelometry
The immunonephelometric assay was performed s end point
immunonephelometry using a Beckmann ICS System s de-
.scribed by Rosseneu et al. (17).
Precipitation of apolipoprotein B-containing lipoproteins
The precipitation of apolipoprotein B-cpntaining lipoproteins
was performed using phosphotungstic acid/MgC!2 (Boehringer
Mannheim, order No. 400971) s described elsewhere (19).
Apolipoprotein A-II determination by RID
The apolipoprotein A-II determination by RID was performed
according to Mancini et al. (20). Antibody solution (400 μΐ)
was mixed with 20 ml 10 g/l agarose solution containing Tris-
barbital-lactate buffer pH 8.6 (0.045 mmol/l Tris, 0.015 mol/l
barbituric acid, 1.9 mmol/l Na azide, 0.21 mmol/l Ca-lactate.
The sample volume was 5 μΐ (diluted 1:50 in 0.15 mol/l NaCl).
As Standard we used the Standard RI(D Reference Standard
Apoproteins human order No. 4910005, Immuno Co., D-6900
Heidelberg, FRG, diluted 1:25, 1:50 and 1:100 in 0.15 mol/l
NaCl. The incubation time was 5 days at room temperature.
The ring diameters were measured after staining with
Coornassie Blue R (Serva, D-6900 Heidelberg, FRG).
Results
Turbidimetric reaction
The kinetics of the alterations of the t rbidimetric
light absorption measured at different concentrations
of apolipoprotein A^II are shown in figure 1. The end
point of the reaction was attained after 60 minutes.
Linearity of turbidimetry
We studied the linearity of the apolipoprotein A-II
determination measured by turbidimetry using a
series of fresh pool serum dilutions. The measured
values were proportional to the sample dilutions
within the tested r nge (0.24 g/l - 0.66 g/l) (flg. 2).
Precision of turbidimetry
The coefficieiit of Variation for the precision in the
series was 3.2% (x ± S.D.: 0.356 ± 0.011 g/l, n =
18). Day to day precision was determined with serum
samples taken from the fresh serum pool and stored
in aliquots at — 70 °C. The coefficient of Variation
for day to day precision was 3.5% (χ ± S.D.: 0.333
± 0.015 g/l, n = 36).
Apolipoprotein A-II measured by turbidimetry in the
supernatant after precipitation of apolipoprotein B-
containing lipoproteins with phosphotungstic cid/
MgCh
Comparison of apolipoprotein A-II data measured
iri native serum (x) and measujred in the supernatant
after precipitation of apolipoprotein B-containing
lipoproteins with phosphotungstic acid/MgCl2 (y) re-
s lted in a good correlation of the <pbtai ed values
(r = 0.91, y = 0.88x + 0.047, n = 30) (fig. 3). The
mean values measured in native serum (x == 0.390
Og/l) and measured in the polyvinylsulphate
supernatant (x = 0.392 g/l) were almost identical.
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Comparison of turbidimetry and immunonephelometry
The immunonephelometric assay and the
turbidimetric measurement of apolipoprotein A-II
gave nearly identical values (r = 0.838, y = 0.925x +
0.029, n = 34) (fig. 4).
Comparison of turbidimetry and RID
Regression analysis of the data obtained by
turbidimetry (y) and by RID (x) indicated that apo-
lipoprotein A-II values in normotriglyceridaemic sera
Fig. 1. Course of reaction of apolipoprotein A-II.
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Fig. 2. Measured apolipoprotein A4I values s a function of
the amount of sample used.
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Fig. 4. Regression analysis of apolipoprotein A-II measured by
end point nephelometry (x) and measured by
turbidimetry (y). r = 0.838, y = 0.925x -h 0.029, n =
34.
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Fig. 3. Regression analysis of apolipoprotein A-II measured in
the supernatant after precipitation of apolipoprotein Fig. 5. Regression analysis of apolipoprotein A-II measured by
B-containing lipoproteins with phosphotungstic acid/ Λττ> '"x —J J u" ·—u:j:—*— ΑΛ s-
MgCl2 (x) and measured in the total serum (y). r =
0.91, y = 0.88x + 0.047, n = 30.
RID (x) and measured by turbidimetry (y) in
normolipidaemic sera (triglycerides <2.28 mmol/1). r =
0.90, y = 0.97X -H 0.021, n = 100).
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(triglycerides <2.28 mmol/1) analysed by both
methods corresponded well (r = 0.90, y = 0.97x +
0.021, n = 100) (fig.5). The mean values measured
by both methods (turbidimetry = 0.395 g/l, RIO
= 0.389 g/l) were nearly identical. A similar cor-
respondence of results was found for hyper-
triglyceridaemic sera (triglycerides >2.28 mmol/1
<6.84 mmol/1) (r = 0.97, y = 0.97x + 0.030, n =
21).
Sample stability
Sample stability was tested by analysing fresh samples
and aliquots of samples which had been stored for
11 months at — 20 °C. There was no significant differ-
ence in values obtained from fresh samples (0.273 g/l)
and from samples stored at -20 °C (0.275 g/l) (mean
of double determinations).
Discussion
High density lipoproteins are a heterogenous group
of macromolecules with different composition and
different physicochemical properties (HDL1? HDL2,
HDL3). For the quantification of HDL it is useful to
measure HDL cholesterol äs well äs HDL
apolipoproteins. However, a substantial problem for
the quantification of apolipoproteins, especially of
apolipoprotein A-II, may be the fact that several
antigenic sites of apolipoprotein A-II are masked
by its protein-protein and protein-lipid interaction
within HDL (12). An exposure of the antigenic sites
may be possible by organic solvent extraction of
plasma (16) or by incubation of HDL with guanidine
hydrochloride (12). Recently an immuno-
nephelometric method for quantification of apo-
lipoprotein A-II in plasma has been developed using
sodium cholate for the exposition of its antigenic sites
(17). Since our data from turbidimetry are in good
agreement with the data from the im-
munonephelometric method, it can be supposed that
the detergent used in our assay will equally expose
the antigenic sites of apolipoprotein A-II without
essentially affecting the antigen-antibody reaction.
This supposition is supported by the good agreement
between the data for apolipoprotein A-II obtained
by RID and by turbidimetry, äs well äs the close
agreement between the values for apolipoprotein -
data measured by turbidimetry'in total serum and
in the apolipoprotein B free supernatant.
A substantial problem in the immunochemical
quantification of apolipoproteins is the application
of a suitable Standard. Since previous studies have
shown that immuno-complexes with isolated A-II
resulted in lower light scattering by immuno^
nephelometry than complexes with delipidated HDL
(16), isolated apolipoprotein A-II may not be suitable
äs a primary Standard. Therefore, isolated HDL3
may be preferred äs a secondary Standard for the
standardisation of apolipoprotein A-II. In the present
study a commercial apolipoprotein A^II Standard was
used which behaved similarly to the serum sample
after treatment with detergent. However, the
lyophilised Standard used for RID was not suitable
for turbidimetric apolipoprotein - assay because
incubation of the Standard with the detergent resulted
in an enhancemerit öf turbidimetry in comparison
with the serum samples.
A great advantage of the turbidimetric measurement
of apolipoprotein A-II is the high precision of this
method. The intra- and interassay CV were only
half of those reported for the immunonephelometric
method (17). Another advantage of our described
method may be the relatively low reagent volume
used and the relatively high velocity of the de-
termination in comparison with other described im-
munochemical methods (16, 17).
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